Evolus (EOLS) Receivables (2019 - 2026)
Evolus (EOLS) recorded Receivables of $62.38 million in Q2 2026, up 30.8% from $47.71 million a year earlier and up 19.5% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Evolus reported Receivables of $54.7 million, up 14.7% from FY2024.
- Annual Receivables has increased for five straight years, with a five-year compound annual growth rate of 41.4% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $47.68 million in FY2024 (+56.2%), $30.53 million in FY2023 (+36.0%), $22.45 million in FY2022 (+53.2%) and $14.66 million in FY2021 (+51.4%).
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q2 2019.
- On a year-over-year basis, Receivables has increased for 17 consecutive quarters, with growth averaging 27.5% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 296.8% in Q4 2022, against a decline of 41.6% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $52.22 million (Q1 2026), $54.7 million (Q4 2025) and $50.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Evolus | 525.47 Mn | 333.16 Mn | 57.18 Mn | 62.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.38 Mn |
| Mar 31, 2026 | 52.22 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 50.44 Mn |
| Jun 30, 2025 | 47.71 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Dec 31, 2024 | 47.68 Mn |
| Sep 30, 2024 | 44.64 Mn |
| Jun 30, 2024 | 43.15 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Dec 31, 2023 | 30.53 Mn |
| Sep 30, 2023 | 30.46 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 23.46 Mn |
| Dec 31, 2022 | 22.45 Mn |
| Sep 30, 2022 | 20.92 Mn |
| Jun 30, 2022 | 21.03 Mn |
| Mar 31, 2022 | 16.80 Mn |
| Dec 31, 2021 | 5.66 Mn |
| Sep 30, 2021 | 13.29 Mn |
API Access
Evolus Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();